Impact of hepatitis B and C virus on kidney transplantation outcome

Hepatology

Volumn 29, Issue 1, 1999, Pages 257-263

  Mathurin, Philippe ^a   Mouquet, Catherine ^a   Poynard, Thierry ^a   Sylla, Cheickna ^a   Benalia, Hadjira ^a   Fretz, Catherine ^a   Thibault, Vincent ^a   Cadranel, Jean François ^a   Bernard, Brigitte ^a   Opolon, Pierre ^a   Coriat, Pierre ^a   Bitker, Marc Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; ORGAN PRESERVATION; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SURVIVAL RATE;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032951872     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290123     Document Type: Article

References (20)

1. Diethelm AG, Deierhoi MH, Sharon LH, Laskow DA, Julian BA, Gaston RS, Bynon JS, et al. Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg 1995;221:446-458.
2. Starzl TE, Weil R, Iwatsuki S, Klintmalm G, Shroter GP, Koep LJ, Iwaki Y, et al. The use of ciclosporin A and prednisone in cadaveric kidney transplantation. Surg Gynecol Obset 1980;151:17-26.
3. Rao KV, Andersen RC. Long-term results and complications in renal recipients: Observations in the second decade. Transplantation 1988;45:45-52.
4. Pol S, Debure A, Degott C, Carnot F, Legendre C, Brechet C, Kreis H. Chronic hepatitis in kidney allograft recipients. Lancet 1990;335:878-880.
5. Genesca J, Vila J, Cordoba J, Sauleda S, Quer J, Esteba JI, Esteban R, et al. Hepatitis C virus infection in renal transplant recipients: Epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol 1995;22:272-277.
6. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, Coleman JC, et al. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992;7:1226-1229.
7. Chung RT, Katlov WN, Dienstag JL, Kaplan LM. Chronic renal failure is frequently associated with false-negative anti-C100 in patients with hepatitis C viremia [Abstract]. Gastroenterology 1991;100:A729.
8. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, Degott C, et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991;100:1432-1434.
9. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, Guttmann RD. Hepatitis B disease in dialysis and transplant patients. Transplantation 1987;44:369-376.
10. Parfrey PS, Forbes RDC, Hutchinson TA, Beaudoin JG, Dauphinee WD, Hollomby DJ, Gutmann RD. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 1984;37:461-466.
11. Parfrey PS, Farge D, Forbes RC, Dandavino R, Kenick S, Guttmann RD. Chronic hepatitis in end-stage renal disease: comparison of HBs Agnegative and HBs Ag-positive patients. Kidney International 1985;28:959-967.
12. Fornairon S, Pol S, Legendre C, Carnot F, Brechot C, Kreis H. Long term virological and pathological impact of renal transplantation on HBV chronic infection. Transplantation 1996;62:297-299.
13. Hiesse C, Buffet C, Neyrat N, Rieu P, Carpentier B, Etienne JP. Impact of HBs antigenemia on long-term patient survival and causes of death after transplantation. Clin Transplant 1992;46:461-467.
14. Pirson Y, Alexandre GPJ, Van Ypersele de Strihou C. Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 1977;296:194-196.
15. Chan TM, Lok ASF, Cheng IKP. Hepatitis C in renal transplant recipients. Transplantation 1991;52:810-813.
16. Chan TM, Lok ASF, Cheng IKP, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993;104:862-868.
17. Kazi S, Prasad S, Pollak R, Holzer T, Heynen C, Fabrega AJ, Pitrak D, et al. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation. Dig Dis Sci 1994;39:961-964.
18. Rhor MS, Lesniewski RR, Rubin CA, Johnson RG, Heise ER, Me Donald JC, Adams PL. Risk of liver disease in HCV-seropositive kidney transplant recipients. Ann Surg 1993;217:512-517.
19. McCruden EAB, Welch S, Batchelor B, Allison MC, Dow B, Follett EAC, Mills PR, et al. Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients. J Med Virol 1994;42:158-163.
20. Brunson ME, Lau JYN, Davis GL, Scornik J, Howard RJ, Pfaff WW. Non-A, non-B hepatitis and elevated serum aminotransferases in renal transplant patients. Transplantation 1993;56:1364-1367.